Detailed Information on Publication Record
2002
Symptomatic Intravenous Antipyretic Therapy: Efficacy of Metamizol, Diclofenac, and Propacetamol
OBOŘILOVÁ, Andrea, Jiří MAYER, Zdeněk POSPÍŠIL and Zdeněk KOŘÍSTEKBasic information
Original name
Symptomatic Intravenous Antipyretic Therapy: Efficacy of Metamizol, Diclofenac, and Propacetamol
Authors
OBOŘILOVÁ, Andrea (203 Czech Republic, guarantor), Jiří MAYER (203 Czech Republic), Zdeněk POSPÍŠIL (203 Czech Republic) and Zdeněk KOŘÍSTEK (203 Czech Republic)
Edition
Journal of Pain and Symptom Management, New York, Elsevier, 2002, 0885-3924
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30200 3.2 Clinical medicine
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
Impact factor
Impact factor: 2.466
RIV identification code
RIV/00216224:14310/02:00007643
Organization unit
Faculty of Science
UT WoS
000180146400009
Keywords in English
Diclofenac; metamizol; propacetamol; fever; febrile neutropenia
Změněno: 22/6/2009 16:29, prof. RNDr. Zdeněk Pospíšil, Dr.
Abstract
V originále
In order to support symptomatic fewer therapy, the non-randomized pilot study deals with the patients' discomfort accompanying fever and the beneficial effects of the symptomatic fever management.
Links
MSM 143100001, plan (intention) |
|